HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.

Abstract
Background: The clinical course of Graves' disease (GD) in women who switched from methimazole (MMI) to potassium iodide (KI) during the first trimester of pregnancy has never been reported in detail. Objective: To investigate the characteristics of GD patients whose thyroid hormone levels increase after substituting KI for MMI. Patients: Two hundred forty women with GD who had been treated with MMI and switched from MMI to inorganic iodide to control hyperthyroidism during the first trimester between January 1, 2005, and March 31, 2018. Results: In 133 (55.4%) of the GD patients, medication was completely tapered during pregnancy, and the other 107 (44.6%) GD patients were taking medication at delivery: 57 were taking KI alone and 50 were taking an antithyroid drug with or without KI. It was difficult to control the maternal thyrotoxicosis of 22 of the 107 patients with KI alone, and a higher dose of MMI compared with the dose at the time of conception was required (worsened group). Multivariate analysis revealed that the TRAb value at the time of switch from MMI to KI was the only factor that predicted continuation of the thyroid suppression medication, but none of the parameters was a predictor of the worsened group. Conclusions: It must be kept in mind that a certain proportion of GD patients escape from the antithyroid effect of iodide and that careful follow-up is necessary after switching a pregnant patient's medication to KI.
AuthorsAi Yoshihara, Jaeduk Yoshimura Noh, Natsuko Watanabe, Yo Kunii, Miho Suzuki, Masako Matsumoto, Nami Suzuki, Marino Hiruma, Mitsuha Morisaki, Akiko Kawaguchi, Kiminori Sugino, Koichi Ito
JournalThyroid : official journal of the American Thyroid Association (Thyroid) Vol. 30 Issue 3 Pg. 451-456 (03 2020) ISSN: 1557-9077 [Electronic] United States
PMID31928169 (Publication Type: Journal Article)
Chemical References
  • Antithyroid Agents
  • Thyroid Hormones
  • Potassium Iodide
  • Methimazole
Topics
  • Adult
  • Antithyroid Agents (therapeutic use)
  • Drug Substitution
  • Female
  • Graves Disease (blood, drug therapy)
  • Humans
  • Methimazole (therapeutic use)
  • Potassium Iodide (therapeutic use)
  • Pregnancy
  • Pregnancy Complications (blood, drug therapy)
  • Pregnancy Trimester, First
  • Thyroid Hormones (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: